430 Results (Page 1 of 18)
UK Markets Research Reports
UK Telemedicine Market Analysis
The UK telemedicine market size was valued at $1.58 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.25% from 2022 to 2030 and will reach $16.2 Bn in 2030. The market is driven by factors such as the increasing adoption of digital health solutions and the growing prevalence of chronic diseases. The market is segmented by Component Type, Application Type, Modality Type, and Delivery Mode Type. The major players in the UK telemedicine market are Babylon Health (UK), Medicspot (UK), Doctor Care Anywhere (UK), Push Doctor (UK), Live Doctor (UK), Doctor on Demand, and others.
UK Electronic Health Records Market Analysis
The UK electronic health record market size was valued at $736 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022 to 2030 and will reach $862 Mn in 2030. This growth can be attributed to Technological advancements in healthcare offering a promising future for enhancing healthcare delivery through electronic health records. The market is segmented by product type, application type, and end user. Some of the major players are Cerner Healthcare, InPS, System C & Graphnet Health, TPP, and others.
UK Digital Health Market Analysis
The UK Digital Health market is projected to grow from $5.49 Bn in 2022 to $18.74 Bn by 2030, registering a CAGR of 16.6% during the forecast period of 2022-30. Higher healthcare funding by the government and growing investments by innovative start-up companies across the UK are the major drivers for the digital health market. The market is segmented by solution, by deployment & by end-use. Some of the major players include Huma, CERA CARE & Cerner Corporation.
UK Home Healthcare Market Analysis
UK's home healthcare market is projected to grow from $9.429 Bn in 2022 to $14.494 Bn by 2030, registering a CAGR of 5.93% during the forecast period of 2022-30. The demand for home healthcare systems in the UK has been significantly impacted by the rising prevalence of chronic diseases. One of the main reasons for the expansion of the UK home healthcare business has been the rise in mergers and acquisitions. Some key players in the UK home healthcare market include Bupa, Care UK, Barchester Healthcare, Four Seasons Health Care, and HC-One.
UK Cholesterol Therapeutics Market Analysis
The UK Cholesterol Therapeutics Market is anticipated to experience a growth from $631.8 Mn in 2022 to $662.8 Mn by 2030, with a CAGR of 0.6% during the forecast period of 2022-2030. The increasing prevalence of high cholesterol, alignment with NHS policies emphasizing cost-effectiveness, and the demand for innovative solutions collectively act as drivers propelling the growth of the UK market. The UK Cholesterol Therapeutics Market encompasses various players across different segments such as Pfizer, Merck, Roche, Novartis, Amgen, AstraZeneca, Hikma Pharmaceuticals, Wockhardt, Alvotec, Omega Pharma, etc., among various others.
UK Physiotherapy Market Analysis
The UK physiotherapy market size was valued at $1.38 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 3.85% from 2022 to 2030 and will reach $1.87 Bn in 2030. The UK physiotherapy market is expected to grow due to an increase in the number of people suffering from chronic conditions as well as an ageing population. The market is segmented by Product Type, Application Type, and End User. The major players in the UK physiotherapy market are Machine Medicine, PneumaCare, Qured, Action First Physiotherapy Ltd, and others.
UK Brain Cancer Therapeutics Market
UK Brain Cancer Therapeutics Market valued at $60 Mn in 2022, projected to reach $116 Mn by 2030 with a 8.6% CAGR. The anticipated increase in cases of brain cancer, particularly glioblastoma multiforme, is expected to markedly boost the need for brain cancer therapeutics, shaping the overall market landscape significantly. The top leading pharmaceutical companies currently operating in the market are Roche, AstraZeneca, Pfizer, Merck & Co., Eli Lilly, Novartis, Gilead Sciences, Bayer, Janssen Pharmaceuticals, and Ipsen.
UK Artificial Intelligence (AI) in Medical Imaging Market Analysis
UK Artificial Intelligence (AI) in Medical Imaging market size was valued at $39 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.4% from 2022 to 2030 and will reach $391 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The UK Artificial Intelligence (AI) in the Medical Imaging market will grow because AI technologies can help improve the accuracy and efficiency of medical imaging, leading to better patient outcomes and reduced healthcare costs. Some of the key players in this market are Optellum, Kheiron Medical, Aidoc, Sophia Genetics, Ultromics, Brainomix, MaxQ AI, Faculty, Sensyne Health, Feedback Medical, Cambridge Medical Imaging, Perspectum, Oxipit, Qure.ai, Quantib, Imagen, Mirada Medical, Kromek Group, GTN, 4D Imaging, and others.
UK Alzheimer’s Therapeutics Market Analysis
UK alzheimer’s therapeutics market valued at $125 Mn in 2022, projected to reach $216 Mn by 2030 with a 7.1% CAGR. One key factor propelling the market for Alzheimer's treatment medications is the rising incidence of Alzheimer's disease which is driven by an aging population. Biogen, Eisai Co, Janssen Pharmaceuticals, Novartis, Pfizer, Lundbeck, Merck & Co, AstraZeneca, Eli Lilly and Accord Healthcare are leading pharmaceutical companies currently operating in the market.
UK Infectious Disease Drugs Market Analysis
UK Infectious Disease Drugs Market valued at $3.08 Bn in 2023, projected to reach $3.61 Bn by 2030 with a 2.27% CAGR. Rising antimicrobial resistance, technological advancements, government initiatives, and funding are some of the factors driving the market. The market is dominated by key players like GlaxoSmithKline plc, AstraZeneca, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Novartis AG, and Sanofi S.A.
UK Atopic Dermatitis Therapeutics Market Analysis
The UK Atopic Dermatitis Therapeutics Market was valued at US $320 Mn in 2022, and is predicted to grow at (CAGR) of 6.8% from 2023 to 2030, to US $541 Mn by 2030. The key drivers of this industry include the rising prevalence of Atopic Dermatitis (AD), evolving treatment landscape of the industry, and high medical unmet needs and diagnoses. The industry is primarily dominated by players such as Pfizer, Astellas, Novartis, Galderma, AbbVie, Anacor, Meda, and Allergan, among others.
UK Atherosclerosis Therapeutics Market Analysis
UK Atherosclerosis Therapeutics Market was valued at $73 Mn in 2022 and is estimated to reach $97 Mn in 2030, exhibiting a CAGR of 3.7% during the forecast period. The market for atherosclerosis therapeutics is expected to rise as a result of the increasing prevalence of cardiovascular illnesses that have been exacerbated by unhealthy eating habits, sedentary lifestyles, and an aging population worldwide. The top leading pharmaceutical companies presently operating in the industry are Pfizer, Novartis, AstraZeneca, Sanofi, Merck & Co., Janssen Pharmaceuticals, Bayer, Abbott, Eli Lilly and Roche.
UK Asthma and COPD Therapeutics Market Analysis
The UK Asthma and COPD Therapeutics Market was valued at US $0.868 Bn in 2022, and is predicted to grow at (CAGR) of 3.20% from 2023 to 2030, to US $1.117 Bn by 2030. The key drivers of this industry include the surge in the prevalence of COPD and asthma, demand for effective treatment, supportive government initiatives, and others. The industry is primarily dominated by players such as AstraZeneca, Novartis, Teva, GSK, Novartis Pfizer, Boehringer Ingelheim, among others
UK HIV Drugs Market Analysis
UK HIV Drugs Market is at around $0.82 Bn in 2023 and is projected to reach $0.92 Bn in 2030, exhibiting a CAGR of 1.6% during the forecast period. Government initiatives, increased access to healthcare, and international partnerships are driving the sector. The market is dominated by key players like ViiV Healthcare, Gilead Sciences, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffman-La Roche Ltd, Johnson & Johnson, and Bayer.
UK Antifungal Drugs Market Analysis
UK Antifungal Drugs Market is at around $0.4 Bn in 2023 and is projected to reach $0.5 Bn in 2030, exhibiting a CAGR of 1.8% during the forecast period. The rise in the market is being driven by the rising prevalence of fungal infections, improvements in healthcare infrastructure, and technological advancements in drug development. The market is dominated by key players like Merck & Co., Inc., Pfizer Inc., Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Novartis AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
UK Dengue Vaccines Market Analysis
UK Dengue Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing dengue burden globally, growing awareness and government initiatives, technological advancements in vaccine development, economic burden reduction, and collaborative efforts between vaccine manufacturers, research organisations, and government agencies are driving the Dengue Vaccines market. Sanofi Pasteur, Takeda Pharmaceutical Company Limited, Butantan Institute, Biological E. Limited, Merck & Co., Bharat Biotech International Limited, Panacea Biotec Limited, GlaxoSmithKline plc, GeneOne Life Science Inc., Inviragen (a subsidiary of Takeda Pharmaceutical Company Limited) are among the global key players in Dengue Vaccines Market.
UK Depression/Major Depressive Disorders (MDD) Market Analysis
UK Depression/Major Depressive Disorders (MDD) Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving the Depression/Major Depressive Disorders (MDD) market include rising global depression prevalence, increased awareness and understanding of mental health issues, advancements in treatment options such as new medications and therapies, rising healthcare expenditure and insurance coverage for mental health, and government initiatives aimed at improving mental healthcare access. Pfizer Inc., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Bristol Myers Squibb Company, H. Lundbeck A/S, Merck & Co., Inc., Allergan plc are global key players in Depression/Major Depressive Disorders (MDD) Market.
UK Diabetes Management Market Analysis
UK Diabetes Management Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Diabetes management market drivers include rising diabetes prevalence, technological advancements in glucose monitoring and insulin delivery systems, increased diabetes awareness and education, government initiatives promoting diabetes management, and rising healthcare expenditure on chronic disease management. Medtronic plc, Abbott Laboratories, Dexcom, Roche Diabetes Care, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, Ascensia Diabetes Care Holdings AG, Becton, Dickinson and Company are global key players in Diabetes Management Market.
UK Diabetic Retinopathy Drugs Market Analysis
UK Diabetic Retinopathy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of diabetic retinopathy, technological advancements in drug development, growing awareness and screening programmes, the ageing population, and government initiatives to improve access to screening and treatment for diabetic retinopathy are the drivers of the Diabetic Retinopathy Drugs market. Novartis AG, Regeneron Pharmaceuticals, Allergan plc (part of AbbVie Inc.), Roche Holding AG, Pfizer Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alimera Sciences, are key global companies in diabetic retinopathy drugs market.
UK Diabetic Retinopathy Therapeutic Market Analysis
UK Diabetic Retinopathy Therapeutic Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of diabetes, growing awareness and early diagnosis, advancements in technology and treatment options, government initiatives and healthcare expenditure, and the aging population are the drivers of the diabetic retinopathy therapeutic market. Prominent global players in the market include Novartis AG, Roche Holdings AG, Regeneron Pharmaceuticals, Bayer AG, Allergan plc (AbbVie Inc.), Alimera Sciences, Bausch Health Companies Inc., Topcon Corporation, Carl Zeiss Meditec AG and NIDEK Co., Ltd.
UK Drugs Addiction Market Analysis
UK Drugs Addiction Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drug addiction market is driven by rising substance usage, increased awareness and public health campaigns, breakthroughs in treatment methods, government initiatives and legislation, and the high frequency of co-occurring mental health issues. Indivior PLC, Alkermes plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Orexo AB, Mylan N.V., Glenmark Pharmaceuticals, Accord Healthcare Ltd., and Camurus AB are global players in the Drug Addiction Market.
UK Dry Eye Medication Market Analysis
UK Dry Eye Medication Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of dry eye, aging population, technological advancements in drug formulations and diagnostics, rising awareness and diagnosis, and lifestyle factors such as increased screen time and air pollution are the drivers of the dry eye medication market. Allergan plc (AbbVie Inc.), Novartis AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alcon, Inc. (a division of Novartis AG), Sun Pharmaceutical Industries Ltd., Otsuka Holdings Co., Taisho Pharmaceutical Co., Ltd, Senju Pharmaceutical Co. Are global companies in Dry Eye Medication Market.
UK Encephalitis Vaccines Market Analysis
UK Encephalitis Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing incidence of encephalitis, growing awareness and immunization programs, technological advancements in vaccine development, global travel and migration, and government support and funding are the drivers of the encephalitis vaccines market. GlaxoSmithKline plc, Sanofi Pasteur, Pfizer Inc., Merck & Co., Novartis AG, Bharat Biotech International Ltd., Takeda Pharmaceutical Company Limited, Biological E. Limited, Valneva SE and Sinovac Biotech Ltd are global companies in encephalitis vaccines market.
UK End-stage Renal Disease(ESRD) Market Analysis
UK End-stage renal disease (ESRD) Market Analysis is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the End-stage renal disease (ESRD) market include the increasing prevalence of chronic kidney diseases, advancements in renal replacement therapies, growing demand for kidney transplantation, government initiatives and healthcare policies supporting renal care, and the aging population. Global Players in the ESRD Market are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd., Medtronic plc, Terumo Corporation and Rockwell Medical, Inc.
UK Endometriosis Drugs Market Analysis
UK Endometriosis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the Endometriosis Drugs market include the increasing prevalence of endometriosis, growing awareness and diagnosis, demand for effective pain management, technological advancements in drug development, and supportive government initiatives. These factors contribute to market growth by addressing unmet needs and improving access to treatment options for endometriosis patients. Global Players in the Endometriosis Drugs Market are AbbVie Inc., Pfizer Inc., Bayer AG, Eli Lilly and Company, Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Teva Pharmaceutical Industries Ltd., Merck & Co. and Takeda Pharmaceutical Company Limited.